伦理的临床试验设计和治疗效果的差异
Roger J Lewis1, Kert Viele1, Margareth Ndomondo-Sigonda2
1Berry Consultants, LLC, 3345 Bee Caves Rd, Suite 201, Austin, Texas78746, United States of America.
Bulletin of the World Health Organization
|October 2, 2025
概括
全球临床试验可能会误导,如果他们认为一种治疗效果适合所有. 层次模型提供了一个解决方案,为所有人群提供特定区域的结果并维护研究中的正义.
科学领域:
- 临床试验 临床试验
- 生物统计学 生物统计学
- 健康 公平 卫生 公平
背景情况:
- 全球临床试验经常估计一个单一的整体治疗效果.
- 这种方法可能会导致误导性结论和道德问题,特别是关于正义的问题.
- 当低资源环境中的研究主要有利于高资源环境时,正义就会受到损害.
研究的目的:
- 提出全球临床试验的方法策略,以解决与司法有关的伦理问题.
- 为了能够估计有效的,人群特定的治疗效应.
- 保持与传统的聚合分析可比的分析效率.
主要方法:
- 利用基于层次模型的方法论策略.
- 应用层次模型来估计每个参与人群的治疗效果.
- 用一个具体的例子展示了这种方法.
主要成果:
- 层次模型使得对每个参与人群有效的治疗效应的估计成为可能.
- 这种方法可以保持与传统的聚合分析相比的效率.
- 在存在大量人口之间的差异时产生有效的区域特定结果.
结论:
- 层次模型提供了一种策略,以确保全球临床试验以道德设计.
- 这种方法有助于维护所有参与人口的正义.
- 将其纳入试验标准将有助于监管机构,资助者和利益相关者确保公平的研究.
相关概念视频
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
182
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
182
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
228
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
228
Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
Crossover Experiments
4.5K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
4.5K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
407
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
407
Blinding
3.8K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.8K


